Literature DB >> 15509553

Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.

Yoshihisa Nakatani1, Hideaki Kaneto, Dan Kawamori, Kazutomi Yoshiuchi, Masahiro Hatazaki, Taka-aki Matsuoka, Kentaro Ozawa, Satoshi Ogawa, Masatsugu Hori, Yoshimitsu Yamasaki, Munehide Matsuhisa.   

Abstract

Type 2 diabetes is one of the most prevalent and serious metabolic diseases in the world, and insulin resistance and pancreatic beta-cell dysfunction are the hallmarks of the disease. In this study, we have shown that endoplasmic reticulum (ER) stress, which is provoked under diabetic conditions, plays a crucial role in the insulin resistance found in diabetes by modifying the expression of oxygen-regulated protein 150 (ORP150), a molecular chaperone that protects cells from ER stress. Sense ORP overexpression in the liver of obese diabetic mice significantly improved insulin resistance and markedly ameliorated glucose tolerance. Conversely, expression of antisense ORP150 in the liver of normal mice decreased insulin sensitivity. The phosphorylation state of IRS-1 and Akt, which are key molecules for insulin signaling, and the expression levels of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, key enzymes of gluconeogenesis, were also altered by ORP150 overexpression. This is the first report showing that ER stress plays a crucial role in the insulin resistance found in diabetes and thus could be a potential therapeutic target for diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15509553     DOI: 10.1074/jbc.M411860200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  169 in total

1.  A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response.

Authors:  Jonathon N Winnay; Jeremie Boucher; Marcelo A Mori; Kohjiro Ueki; C Ronald Kahn
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

2.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress.

Authors:  Adama Kamagate; Dae Hyun Kim; Ting Zhang; Sandra Slusher; Roberto Gramignoli; Stephen C Strom; Suzanne Bertera; Steven Ringquist; H Henry Dong
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

3.  Endoplasmic reticulum chaperon tauroursodeoxycholic acid alleviates obesity-induced myocardial contractile dysfunction.

Authors:  Asli F Ceylan-Isik; Nair Sreejayan; Jun Ren
Journal:  J Mol Cell Cardiol       Date:  2010-10-28       Impact factor: 5.000

Review 4.  Alternative macrophage activation and metabolism.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 5.  Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation?

Authors:  Muthuswamy Balasubramanyam; Rangasamy Sampathkumar; Viswanathan Mohan
Journal:  Mol Cell Biochem       Date:  2005-07       Impact factor: 3.396

6.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

7.  Repression of GLUT4 expression by the endoplasmic reticulum stress response in 3T3-L1 adipocytes.

Authors:  Ryan S Miller; Daniel Diaczok; David W Cooke
Journal:  Biochem Biophys Res Commun       Date:  2007-08-09       Impact factor: 3.575

8.  Endoplasmic reticulum stress markers are associated with obesity in nondiabetic subjects.

Authors:  Neeraj K Sharma; Swapan K Das; Ashis K Mondal; Oksana G Hackney; Winston S Chu; Philip A Kern; Neda Rasouli; Horace J Spencer; Aiwei Yao-Borengasser; Steven C Elbein
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

Review 9.  Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Xue-Qun Zhang; Cheng-Fu Xu; Chao-Hui Yu; Wei-Xing Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.

Authors:  Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  J Mol Med (Berl)       Date:  2005-03-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.